US$ 20.96
gip/glp-1 receptor agonist mechanism of action Mechanisms of GLP-1RA Glucagon-like peptide-1 receptor: mechanisms and
Description
Not for use during pregnancy or nursing without guidance from your provider

no major safety concerns were observed
Guidelines currently recommend organ-specific management of obesity-related complications

Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration

Read more
